Uptake of pertussis immunization in pregnancy and determinants of vaccination in Toronto, Canada

James Wright1, Michelle Science2, Selma Osman3

  • 1Public Health Ontario, Toronto, Ontario, Canada.

Vaccine
|October 16, 2023
PubMed

Insights

Maternal pertussis vaccination uptake in Toronto increased from 2018-2020, but remains below desired levels. Vaccination rates were higher for those pregnant in more recent years and for mothers born in Canada.

Area of Science:

  • Public Health
  • Immunization
  • Maternal Health

Background:

  • Pertussis (whooping cough) poses significant risks to infants under six months.
  • Maternal pertussis vaccination during pregnancy is recommended in Canada to protect infants.
  • Data on vaccination coverage in Canada was lacking.

Purpose of the Study:

  • To evaluate the uptake of maternal pertussis vaccination in Toronto, Canada.
  • To identify factors associated with pertussis vaccination during pregnancy.

Main Methods:

  • Recruitment of mother-infant pairs at The Hospital for Sick Children, Toronto (2018-2020).
  • Logistic regression analysis to assess demographic associations with self-reported vaccination.

Main Results:

  • 31.3% (76/243) of mothers received pertussis vaccination during pregnancy.
  • Vaccination odds increased significantly with each year of pregnancy and for mothers born in Canada.

Conclusions:

  • Maternal pertussis vaccination uptake in Ontario has risen recently.
  • Coverage rates are still lower than optimal, indicating a need for further improvement.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.6K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
320
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K